Literature DB >> 2137332

Thermodynamic analysis of the interaction of the antibiotic teicoplanin and its aglycone with cell-wall peptides.

P Arriaga1, J Laynez, M Menendez, J Cañada, F Garcia-Blanco.   

Abstract

The thermodynamics of the interaction of the glycopeptidic antibiotic teicoplanin and its peptidic moiety with analogues of bacterial cell-wall peptides were studied by means of calorimetric and spectrophotometric techniques. The analysis of the thermodynamic data has allowed us to evaluate the contributions of the different peptide groups to the binding process. The nature of the primary binding forces is also discussed for each interacting group, on the basis of their enthalpic and entropic contribution and in connection with the detailed structural information available for these antibiotics from n.m.r. data. Similar analyses for the case of vancomycin and ristocetin are also reported.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137332      PMCID: PMC1136615          DOI: 10.1042/bj2650069

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  A structure-activity study by nuclear magnetic resonance of peptide interactions with vancomycin.

Authors:  J P Brown; L Terenius; J Feeney; A S Burgen
Journal:  Mol Pharmacol       Date:  1975-03       Impact factor: 4.436

2.  Crisis intervention for parents of the deaf child.

Authors:  D Spink
Journal:  Health Soc Work       Date:  1976-11

3.  Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine.

Authors:  G M Sheldrick; P G Jones; O Kennard; D H Williams; G A Smith
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

4.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

Authors:  F Parenti; G Beretta; M Berti; V Arioli
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

5.  Biological properties of ristocetin-ps-aglycone.

Authors:  R V Nielsen; F Hyldig-Nielsen; K Jacobsen
Journal:  J Antibiot (Tokyo)       Date:  1982-11       Impact factor: 2.649

6.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.

Authors:  M R Bardone; M Paternoster; C Coronelli
Journal:  J Antibiot (Tokyo)       Date:  1978-03       Impact factor: 2.649

7.  In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.

Authors:  P E Varaldo; E Debbia; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

8.  Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.

Authors:  R Pallanza; M Berti; B P Goldstein; E Mapelli; E Randisi; R Scotti; V Arioli
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

9.  The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

10.  Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  3 in total

1.  A carrier protein strategy yields the structure of dalbavancin.

Authors:  Nicoleta J Economou; Virginie Nahoum; Stephen D Weeks; Kimberly C Grasty; Isaac J Zentner; Tracy M Townsend; Mohammad W Bhuiya; Simon Cocklin; Patrick J Loll
Journal:  J Am Chem Soc       Date:  2012-03-01       Impact factor: 15.419

2.  Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach.

Authors:  Nicoleta J Economou; Isaac J Zentner; Edwin Lazo; Jean Jakoncic; Vivian Stojanoff; Stephen D Weeks; Kimberly C Grasty; Simon Cocklin; Patrick J Loll
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-03-14

3.  In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.